E
Sana Biotechnology, Inc. SANA
$1.71 -$0.06-3.39% NASDAQ
Recommendation
Prev Close
$1.77
Volume
948,597
Avg Vol (90D)
6,210,598
Market Cap
$398.29M
Dividend & Yield
--
52-Week Range
$1.26 - $10.50
P/E (TTM)
--
EPS (TTM)
-$1.17
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There May Still Be Time to Get in on These 3 Trending Biotechs
1/20/2025 - MarketBeat
Shareholders that lost money on Sana Biotechnology, Inc.(SANA) should contact The Gross Law Firm about pending Class Action - SANA
4/28/2025 - Globe Newswire
SANA LAWSUIT ALERT: The Gross Law Firm Notifies Sana Biotechnology, Inc. ...
4/28/2025 - GuruFocus
SANA LAWSUIT ALERT: The Gross Law Firm Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
4/28/2025 - PR Newswire
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, ...
4/27/2025 - GuruFocus
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
4/27/2025 - Globe Newswire
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Sana Biotechnology, Inc. ...
4/27/2025 - GuruFocus
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action SANA
4/27/2025 - Globe Newswire
XTX Topco Ltd Makes New Investment in Sana Biotechnology, Inc. (NASDAQ:SANA)
4/27/2025 - MarketBeat
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
4/26/2025 - Globe Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers SANA
4/25/2025 - Globe Newswire
Contact Levi & Korsinsky by May 20, 2025 Deadline to Join Class Action Against Sana Biotechnology, Inc.(SANA)
4/25/2025 - PR Newswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Sana Biotechnology, Inc. ...
4/24/2025 - GuruFocus
ROSEN, A LONGSTANDING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action SANA
4/24/2025 - Globe Newswire
Levi & Korsinsky Reminds Sana Biotechnology, Inc. ...
4/24/2025 - GuruFocus
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 SANA
4/24/2025 - Globe Newswire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. ...
4/24/2025 - GuruFocus
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
4/24/2025 - PR Newswire
Shareholders that lost money on Sana Biotechnology, Inc. ...
4/24/2025 - GuruFocus
Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare
4/24/2025 - PR Newswire
Shareholders that lost money on Sana Biotechnology, Inc.(SANA) should contact The Gross Law Firm about pending Class Action - SANA
4/24/2025 - PR Newswire
Class Action Filed Against Sana Biotechnology, Inc. ...
4/23/2025 - GuruFocus
Class Action Filed Against Sana Biotechnology, Inc. (SANA) - May 20, 2025 Deadline to Join Contact The Gross Law Firm
4/23/2025 - Globe Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
4/23/2025 - Globe Newswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANA
4/22/2025 - PR Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$255.97M
EBIT (TTM)
-$271.47M
Net Income (TTM)
-$266.76M
Balance Sheet
Total Assets (Q)
$501.02M
Total Debt (Q)
$101.90M
Total Liabilities (Q)
$250.52M
Book Value Per Share (Q)
$1.12
Cash Flow
Cash from Operations (TTM)
-$223.15M
Cash from Investing (TTM)
$17.45M
Cash from Financing (TTM)
$199.75M
Net Change in Cash (TTM)
-$5.95M
Filings
Filing Date
Monday, March 17, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.04
7-Day Total Return
8.23%
30-Day Total Return
-41.64%
60-Day Total Return
-51.00%
90-Day Total Return
-9.52%
Year to Date Total Return
3.64%
1-Year Total Return
-80.39%
2-Year Total Return
-67.30%
3-Year Total Return
-76.61%
5-Year Total Return
--
52-week Low
Apr 04, 2025 - $1.26
52-week High
May 06, 2024 - $10.50
Valuation
Market Cap
$398.29M - Small Cap
Enterprise Value
$347.69M
Price/Sales (TTM)
--
Price/Book (Q)
1.58
Dividends and Shares
Shares Outstanding
236.30M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.sana.com
Phone Number
206 701 7914
Address
188 East Blaine Street
Seattle, WA 98102
Country
United States
Year Founded
2018
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various... more
NASDAQ 04/28/2025 12:18PM Eastern Quotes delayed